Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

BrainJuicer Group 2011 Profit Increases - Quick Facts

BrainJuicer Group Plc (BJU.L) said its 2011 profit attributable to equity holders was up to 1.85 million pounds or 14.1 pence per share from 1.48 million pounds or 11.3 pence per share last year.

Pre-tax profit was 2.76 million pounds, higher than 2.22 million pounds a year earlier.

Revenue grew to 20.71 million pounds from 16.36 million pounds a year ago. This growth stemmed from the organic development of the business.

In addition, the Board is proposing a final dividend of 2.25 pence, 25% higher than for 2010.

Commenting on the company's results, John Kearon, Founder and Chief Juicer of BrainJuicer, said,

"We are pleased to report another period of strong organic growth. ..Our revenue visibility is, as ever, limited but we are confident that the Company will make further progress in 2012."

Click here to receive FREE breaking news email alerts for BrainJuicer Group and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
After ending the previous session modestly lower, stocks have shown a strong move back to the upside during trading on Tuesday. With the upward move on the day, the S&P 500 has reached a new record intraday high. A majority of Americans believe Israel is justified in taking military action against Gaza, according to the results of a new CNN/ORC International survey, although opinions about the amount of military force the Israelis have used are more divided. After reporting a sharp increase in existing home sales in the previous month, the National Association of Realtors released a report on Tuesday showing that existing home sales once again rose by more than expected in the month of June.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.